PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CPRX vs. CL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CPRXCL
YTD Return-7.26%23.47%
1Y Return18.56%29.29%
3Y Return (Ann)38.49%9.14%
5Y Return (Ann)33.96%8.23%
10Y Return (Ann)20.24%6.13%
Sharpe Ratio0.412.03
Daily Std Dev43.58%14.01%
Max Drawdown-94.25%-67.62%
Current Drawdown-25.94%0.00%

Fundamentals


CPRXCL
Market Cap$1.81B$77.74B
EPS$0.56$3.15
PE Ratio27.3830.08
PEG Ratio0.002.15
Total Revenue (TTM)$411.35M$19.75B
Gross Profit (TTM)$347.75M$11.64B
EBITDA (TTM)$114.04M$4.60B

Correlation

-0.50.00.51.00.1

The correlation between CPRX and CL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CPRX vs. CL - Performance Comparison

In the year-to-date period, CPRX achieves a -7.26% return, which is significantly lower than CL's 23.47% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 20.24%, while CL has yielded a comparatively lower 6.13% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


100.00%150.00%200.00%250.00%300.00%350.00%2024FebruaryMarchAprilMayJune
155.57%
351.50%
CPRX
CL

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Catalyst Pharmaceuticals, Inc.

Colgate-Palmolive Company

Risk-Adjusted Performance

CPRX vs. CL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CPRX
Sharpe ratio
The chart of Sharpe ratio for CPRX, currently valued at 0.41, compared to the broader market-2.00-1.000.001.002.003.000.41
Sortino ratio
The chart of Sortino ratio for CPRX, currently valued at 0.85, compared to the broader market-4.00-2.000.002.004.000.85
Omega ratio
The chart of Omega ratio for CPRX, currently valued at 1.11, compared to the broader market0.501.001.502.001.11
Calmar ratio
The chart of Calmar ratio for CPRX, currently valued at 0.40, compared to the broader market0.002.004.006.000.40
Martin ratio
The chart of Martin ratio for CPRX, currently valued at 1.52, compared to the broader market-5.000.005.0010.0015.0020.0025.001.52
CL
Sharpe ratio
The chart of Sharpe ratio for CL, currently valued at 2.03, compared to the broader market-2.00-1.000.001.002.003.002.03
Sortino ratio
The chart of Sortino ratio for CL, currently valued at 2.79, compared to the broader market-4.00-2.000.002.004.002.79
Omega ratio
The chart of Omega ratio for CL, currently valued at 1.36, compared to the broader market0.501.001.502.001.36
Calmar ratio
The chart of Calmar ratio for CL, currently valued at 1.80, compared to the broader market0.002.004.006.001.80
Martin ratio
The chart of Martin ratio for CL, currently valued at 7.66, compared to the broader market-5.000.005.0010.0015.0020.0025.007.66

CPRX vs. CL - Sharpe Ratio Comparison

The current CPRX Sharpe Ratio is 0.41, which is lower than the CL Sharpe Ratio of 2.03. The chart below compares the 12-month rolling Sharpe Ratio of CPRX and CL.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002024FebruaryMarchAprilMayJune
0.41
2.03
CPRX
CL

Dividends

CPRX vs. CL - Dividend Comparison

CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 1.99%.


TTM20232022202120202019201820172016201520142013
CPRX
Catalyst Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CL
Colgate-Palmolive Company
1.99%2.40%2.36%2.10%2.05%2.48%2.79%2.11%2.37%2.25%2.05%2.04%

Drawdowns

CPRX vs. CL - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -67.62%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%2024FebruaryMarchAprilMayJune
-25.94%
0
CPRX
CL

Volatility

CPRX vs. CL - Volatility Comparison

Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 8.86% compared to Colgate-Palmolive Company (CL) at 4.36%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%2024FebruaryMarchAprilMayJune
8.86%
4.36%
CPRX
CL

Financials

CPRX vs. CL - Financials Comparison

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items